Avidian Wealth Enterprises’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,076
Closed -$150K 435
2022
Q2
$150K Buy
3,076
+197
+7% +$9.61K 0.01% 427
2022
Q1
$173K Buy
+2,879
New +$173K 0.01% 457